ARTICLE | Management Tracks
Takeda makes waves again with CEO pick
Plus: Roche hires a chief digital technology officer, and updates from Gain, Allogene, Airna, Osta and more
January 31, 2025 2:09 AM UTC
Julie Kim will succeed Christophe Weber as CEO of Takeda Pharmaceutical Co. Ltd. (Tokyo:4502; NYSE:TAK) in June 2026, pending shareholder approval. Kim joined Takeda in 2019 and became president of the company’s U.S. business unit in 2022. Weber, who is set to retire from Takeda and relinquish his board seat, joined as COO in 2014 after a 21-year stint at GSK plc (LSE:GSK; NYSE:GSK).
With the selection of Kim, a Korean-American, to lead the 240-year-old Japanese pharma, Takeda has once again made waves by hiring a woman to its top post. Takeda’s hire of Weber, a French national, shook up the local biopharma community when he ascended to the CEO role in 2015...